MedPath

Effects of Neutrophil/Lymphocyte, Platelet/Lymphocyte, CRP/Albumin and Lactate on Mortality in Trauma Patients Admitted to Intensive Care

Completed
Conditions
Intensive Care
Registration Number
NCT06667310
Lead Sponsor
Harran University
Brief Summary

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients.

Detailed Description

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients. The researchers aimed to evaluate the relationship between Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and biomarkers such as Lactate and Base Deficit with the clinical course and survival of trauma patients admitted to the ICU and to see the compatibility of our data with the existing literature.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
    1. All trauma patients admitted to our general intensive care unit
Exclusion Criteria
    1. Patients whose follow-up and treatment started and completed in the services.
  1. Patients whose data is missing or whose data cannot be accessed.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomeone day

1. LACTATE LEVELS RATİO MEASUREMENT

Secondary Outcome Measures
NameTimeMethod
seconary outcomeone day

The effect of these measurements on mortality

Trial Locations

Locations (1)

Veli Fahri Pehlivan

🇹🇷

Karaköprü, Şanliurfa, Turkey

© Copyright 2025. All Rights Reserved by MedPath